Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3.

Area of Science:

• Biochemistry
• Immunology
• Peptide Synthesis

Background:

• Human β-defensin 3 (HBD-3) is a crucial antimicrobial and immunomodulatory peptide involved in host defense.
• HBD-3 interacts with cell membranes and acts as a ligand for various receptors, including melanocortin and cytokine receptors, and voltage-gated potassium channels.
• Previous structural and functional studies of HBD-3 were limited by inefficient synthetic and recombinant expression methods.

Purpose of the Study:

• To develop an optimized Fmoc solid-phase synthesis strategy for human β-defensin 3 (HBD-3).
• To improve the efficiency and yield of HBD-3 peptide synthesis.
• To explore alternative disulfide bond formation strategies, including the use of diselenide bonds, to enhance oxidative folding.

Main Methods:

• Utilized optimized resin, coupling reagents, and pseudoproline dipeptide building blocks for Fmoc solid-phase synthesis.
• Employed an orthogonal disulfide bond formation strategy.
• Investigated the replacement of a native disulfide bridge with a diselenide bond for improved oxidative folding.

Main Results:

• The optimized synthesis significantly decreased chain aggregation and improved the yield of the target HBD-3 peptide.
• The use of pseudoproline dipeptide building blocks enhanced the efficiency of the synthesis.
• Replacing a native disulfide bridge with a diselenide bond improved the oxidative folding process.

Conclusions:

• The developed optimized Fmoc solid-phase synthesis method enhances the efficiency and yield of HBD-3 production.
• The alternative synthesis using a diselenide bond offers improved oxidative folding.
• These advancements enable comprehensive biological and pharmacological characterization of HBD-3, advancing its therapeutic potential.